297 related articles for article (PubMed ID: 30014269)
1. A longitudinal study of the association of the eicosapentaenoic acid/arachidonic acid ratio derived from fish consumption with the serum lipid levels: a pilot study.
Tani S; Matsuo R; Matsumoto N
Heart Vessels; 2019 Jan; 34(1):189-196. PubMed ID: 30014269
[TBL] [Abstract][Full Text] [Related]
2. A cross-sectional and longitudinal study between association of n-3 polyunsaturated fatty acids derived from fish consumption and high-density lipoprotein heterogeneity.
Tani S; Matsuo R; Kawauchi K; Yagi T; Atsumi W; Hirayama A
Heart Vessels; 2018 May; 33(5):470-480. PubMed ID: 29159568
[TBL] [Abstract][Full Text] [Related]
3. Association of Fish Consumption-Derived Ratio of Serum n-3 to n-6 Polyunsaturated Fatty Acids and Cardiovascular Risk With the Prevalence of Coronary Artery Disease.
Tani S; Takahashi A; Nagao K; Hirayama A
Int Heart J; 2015 May; 56(3):260-8. PubMed ID: 25902881
[TBL] [Abstract][Full Text] [Related]
4. The Ratio of Eicosapentaenoic Acid (EPA) to Arachidonic Acid may be a Residual Risk Marker in Stable Coronary Artery Disease Patients Receiving Treatment with Statin Following EPA Therapy.
Tani S; Nagao K; Kawauchi K; Yagi T; Atsumi W; Matsuo R; Hirayama A
Am J Cardiovasc Drugs; 2017 Oct; 17(5):409-420. PubMed ID: 28634822
[TBL] [Abstract][Full Text] [Related]
5. Relationships of Fatty Acids, Delta-5 Desaturase Activity, and Lipid Profiles in Men with Acute Coronary Syndrome.
Arai K; Koba S; Yokota Y; Tsunoda F; Tsujita H; Kondo S; Tsukamoto S; Shoji M; Shinke T
J Atheroscler Thromb; 2020 Nov; 27(11):1216-1229. PubMed ID: 32595194
[TBL] [Abstract][Full Text] [Related]
6. Association between ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cardiovascular disease: the Hisayama Study.
Ninomiya T; Nagata M; Hata J; Hirakawa Y; Ozawa M; Yoshida D; Ohara T; Kishimoto H; Mukai N; Fukuhara M; Kitazono T; Kiyohara Y
Atherosclerosis; 2013 Dec; 231(2):261-7. PubMed ID: 24267237
[TBL] [Abstract][Full Text] [Related]
7. Administration of eicosapentaenoic acid may alter lipoprotein particle heterogeneity in statin-treated patients with stable coronary artery disease: A pilot 6-month randomized study.
Tani S; Yagi T; Matsuo R; Kawauchi K; Atsumi W; Matsumoto N; Okumura Y
J Cardiol; 2020 Nov; 76(5):487-498. PubMed ID: 32636128
[TBL] [Abstract][Full Text] [Related]
8. The ratio of serum n-3 to n-6 polyunsaturated fatty acids is associated with diabetes mellitus in patients with prior myocardial infarction: a multicenter cross-sectional study.
Takahashi M; Ando J; Shimada K; Nishizaki Y; Tani S; Ogawa T; Yamamoto M; Nagao K; Hirayama A; Yoshimura M; Daida H; Nagai R; Komuro I
BMC Cardiovasc Disord; 2017 Jan; 17(1):41. PubMed ID: 28125968
[TBL] [Abstract][Full Text] [Related]
9. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
Singh S; Arora RR; Singh M; Khosla S
Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
[TBL] [Abstract][Full Text] [Related]
10. Increased triglyceride/high-density lipoprotein cholesterol ratio may be associated with reduction in the low-density lipoprotein particle size: assessment of atherosclerotic cardiovascular disease risk.
Yokoyama K; Tani S; Matsuo R; Matsumoto N
Heart Vessels; 2019 Feb; 34(2):227-236. PubMed ID: 30140959
[TBL] [Abstract][Full Text] [Related]
11. Which has the stronger impact on coronary artery disease, eicosapentaenoic acid or docosahexaenoic acid?
Iwamatsu K; Abe S; Nishida H; Kageyama M; Nasuno T; Sakuma M; Toyoda S; Inoue T
Hypertens Res; 2016 Apr; 39(4):272-5. PubMed ID: 26739870
[TBL] [Abstract][Full Text] [Related]
12. Administration of eicosapentaenoic acid may alter high-density lipoprotein heterogeneity in statin-treated patients with stable coronary artery disease: A 6-month randomized trial.
Tani S; Matsuo R; Yagi T; Matsumoto N
J Cardiol; 2020 Mar; 75(3):282-288. PubMed ID: 31543378
[TBL] [Abstract][Full Text] [Related]
13. Association of lecithin-cholesterol acyltransferase activity and low-density lipoprotein heterogeneity with atherosclerotic cardiovascular disease risk: a longitudinal pilot study.
Yokoyama K; Tani S; Matsuo R; Matsumoto N
BMC Cardiovasc Disord; 2018 Dec; 18(1):224. PubMed ID: 30518338
[TBL] [Abstract][Full Text] [Related]
14. Aberrant serum polyunsaturated fatty acids profile is relevant with acute coronary syndrome.
Sakamoto A; Saotome M; Hosoya N; Kageyama S; Yoshizaki T; Takeuchi R; Murata K; Nawada R; Onodera T; Takizawa A; Satoh H; Hayashi H
Heart Vessels; 2016 Aug; 31(8):1209-17. PubMed ID: 26233644
[TBL] [Abstract][Full Text] [Related]
15. Eicosapentaenoic acid in serum phospholipids relates to a less atherogenic lipoprotein profile in subjects with familial hypercholesterolemia.
Sala-Vila A; Cofán M; Mateo-Gallego R; Cenarro A; Civeira F; Ros E
J Nutr Biochem; 2013 Sep; 24(9):1604-8. PubMed ID: 23618530
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of eicosapentaenoic acid/arachidonic acid ratio (EPA/AA) in adult patients with congenital heart disease.
Kanoh M; Inai K; Shinohara T; Tomimatsu H; Nakanishi T
Heart Vessels; 2017 Dec; 32(12):1513-1522. PubMed ID: 28681101
[TBL] [Abstract][Full Text] [Related]
17. Effects of a fish-based diet and administration of pure eicosapentaenoic acid on brachial-ankle pulse wave velocity in patients with cardiovascular risk factors.
Fukuoka Y; Nuruki N; Amiya S; Tofuku K; Aosaki S; Tsubouchi H
J Cardiol; 2014 Mar; 63(3):211-7. PubMed ID: 24080436
[TBL] [Abstract][Full Text] [Related]
18. Polyunsaturated Fatty Acid Impact on Clinical Outcomes in Acute Coronary Syndrome Patients With Dyslipidemia: Subanalysis of HIJ-PROPER.
Arashi H; Yamaguchi J; Kawada-Watanabe E; Koyanagi R; Sekiguchi H; Mori F; Haruta S; Ishii Y; Murasaki S; Suzuki K; Yamauchi T; Ogawa H; Hagiwara N
J Am Heart Assoc; 2019 Aug; 8(16):e012953. PubMed ID: 31390907
[TBL] [Abstract][Full Text] [Related]
19. Eicosapentaenoic acid to arachidonic acid (EPA/AA) ratio as an associated factor of high risk plaque on coronary computed tomography in patients without coronary artery disease.
Nagahara Y; Motoyama S; Sarai M; Ito H; Kawai H; Takakuwa Y; Miyagi M; Shibata D; Takahashi H; Naruse H; Ishii J; Ozaki Y
Atherosclerosis; 2016 Jul; 250():30-7. PubMed ID: 27175609
[TBL] [Abstract][Full Text] [Related]
20. Association of plasminogen activator inhibitor-1 and low-density lipoprotein heterogeneity as a risk factor of atherosclerotic cardiovascular disease with triglyceride metabolic disorder: a pilot cross-sectional study.
Iida K; Tani S; Atsumi W; Yagi T; Kawauchi K; Matsumoto N; Hirayama A
Coron Artery Dis; 2017 Nov; 28(7):577-587. PubMed ID: 28692480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
